P1535: SAFETY AND TOLERABILITY OF SINGLE ESCALATING DOSES OF INTRAVENOUS NIPOCALIMAB IN HEALTHY JAPANESE ADULTS: A RANDOMIZED, PHASE 1 PLACEBO-CONTROLLED STUDY
J. Leu,
A. Vermeulen,
L. Ling
Affiliations
J. Leu
1 Janssen Research and Development, LLC, Spring House, PA, United States of America
A. Vermeulen
2 Janssen Research & Development, a division of Janssen Pharmaceutica NV, Beerse, Belgium
L. Ling
3 Janssen Research & Development, LLC, Cambridge, MA, United States of America